Filter Results:
(6,984)
Show Results For
- All HBS Web
(6,984)
- People (27)
- News (2,575)
- Research (3,457)
- Events (14)
- Multimedia (224)
- Faculty Publications (2,233)
Show Results For
- All HBS Web
(6,984)
- People (27)
- News (2,575)
- Research (3,457)
- Events (14)
- Multimedia (224)
- Faculty Publications (2,233)
- September 2020 (Revised January 2021)
- Case
Catalys Pacific
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After... View Details
Keywords: Pharmaceutical Companies; Biotech; Health Care; Entrepreneur; Innovation; International Business; Entrepreneurial Finance; Entrepreneurship; Finance; Innovation Strategy; Venture Capital; Strategy; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; Biotechnology Industry; Tokyo
Krieger, Joshua Lev. "Catalys Pacific." Harvard Business School Case 821-035, September 2020. (Revised January 2021.)
- July 24, 2024
- Article
Providing Value and Equity in Medicare's Dementia Care Is a Must
By: Susanna Gallani and Lidia Moura
Keywords: Health Care and Treatment
Gallani, Susanna, and Lidia Moura. "Providing Value and Equity in Medicare's Dementia Care Is a Must." Newsweek (July 24, 2024).
- 17 Jun 2021
- News
Too Few Women Get to Invent – That’s a Problem for Women’s Health
- May 2024
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
By: Caroline Marra and Ariel D. Stern
Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting... View Details
Keywords: Health Care and Treatment; Technological Innovation; Product Development; Health Testing and Trials; Governing Rules, Regulations, and Reforms
Marra, Caroline, and Ariel D. Stern. "Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms." Clinical Pharmacology & Therapeutics 115, no. 5 (May 2024): 988–992.
- September 2016
- Article
Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer
By: Nikhil G. Thaker, Tariq N. Ali, Michael E. Porter, Thomas W. Feeley, Robert S. Kaplan and Steven J. Frank
Question: Can we create a value-based tool to visualize the outcomes and cost of various treatments that could facilitate patient-centered decision making?
Summary Answer: We developed a standardized value framework by using radar charts to visualize and... View Details
Summary Answer: We developed a standardized value framework by using radar charts to visualize and... View Details
Thaker, Nikhil G., Tariq N. Ali, Michael E. Porter, Thomas W. Feeley, Robert S. Kaplan, and Steven J. Frank. "Communicating Value in Healthcare Using Radar Charts: A Case Study of Prostate Cancer." Journal of Oncology Practice 12, no. 9 (September 2016): 813–820.
- February 2019
- Article
Who Benefits Most in Disease Management Programs: Improving Target Efficiency
By: Timothy Simcoe, Maryaline Catillon and Paul Gertler
Disease management programs aim to reduce cost by improving the quality of care for chronic diseases. Evidence of their effectiveness is mixed. Reducing health care spending sufficiently to cover program costs has proved particularly challenging. This study uses a... View Details
Keywords: Health Economics; Target Efficiency; Diabetes; Disease Management; Program Evaluation; Heterogeneity; Economics; Health; Quality; Health Care and Treatment; Cost Management; Health Industry
Simcoe, Timothy, Maryaline Catillon, and Paul Gertler. "Who Benefits Most in Disease Management Programs: Improving Target Efficiency." Health Economics 28, no. 2 (February 2019): 189–203.
- 18 Aug 2020
- News
Vaccines Use Bizarre Stuff. We Need a Supply Chain Now.
- May 2017
- Teaching Plan
Neurotrack and the Alzheimer's Puzzle
By: Richard G. Hamermesh and Carin-Isabel Knoop
Teaching Note for HBS No. 816-072. View Details
- 15 Feb 2022
- Blog Post
Health Is Wealth | The Path To Creating A Venture
opportunities to leverage technology to help people experience their healthcare in a better way. Driven by her own personal health experiences in where she constantly used a guess and check methodology to... View Details
- October 2020 (Revised March 2022)
- Supplement
The What Works Centre: Using Behavioral Science to Improve Social Worker Well-being (B)
By: Ashley V. Whillans and Shibeal O'Flaherty
This case describes the experiences of Michael Sanders—the Chief Executive of the What Works Center for Children’s Social Care—as he led the design and implementation of a program of research aimed at improving the social care system in the United Kingdom (UK) at the... View Details
Keywords: Non-cash Compensation; Behavioral Science; Employees; Well-being; Compensation and Benefits; United Kingdom
Whillans, Ashley V., and Shibeal O'Flaherty. "The What Works Centre: Using Behavioral Science to Improve Social Worker Well-being (B)." Harvard Business School Supplement 921-022, October 2020. (Revised March 2022.)
- October 2020 (Revised March 2022)
- Case
The What Works Centre: Using Behavioral Science to Improve Social Worker Well-being (A)
By: Ashley V. Whillans and Shibeal O'Flaherty
This case describes the experiences of Michael Sanders—the Chief Executive of the What Works Center for Children’s Social Care—as he led the design and implementation of a program of research aimed at improving the social care system in the United Kingdom (UK) at the... View Details
Keywords: Non-cash Compensation; Behavioral Science; Employees; Welfare; Compensation and Benefits; Well-being; United Kingdom
Whillans, Ashley V., and Shibeal O'Flaherty. "The What Works Centre: Using Behavioral Science to Improve Social Worker Well-being (A)." Harvard Business School Case 921-020, October 2020. (Revised March 2022.)
- January 2011 (Revised June 2011)
- Case
Fixed Income Arbitrage in a Financial Crisis (A): US Treasuries in November 2008
Investment manager James Franey confronts an apparent arbitrage opportunity during the global financial crisis of 2008 when he notices a wide yield spread between two U.S. Treasury bonds that mature on the same date. Franey must decide if there is an opportunity, how... View Details
Keywords: Bonds; Valuation; Interest Rates; Financial Crisis; Financial Services Industry; United States
Taliaferro, Ryan D., and Stephen Blyth. "Fixed Income Arbitrage in a Financial Crisis (A): US Treasuries in November 2008." Harvard Business School Case 211-049, January 2011. (Revised June 2011.)
- 08 Feb 2022
- Blog Post
Get to Know Past New Venture Competition Winners: Everly Health
and their time at HBS helped shape their entrepreneurial journey. Alumni Track: Julia Cheek (MBA 2011), CEO and Founder, Everly Health What inspired you to start your company or organization? I started my company to create a better... View Details
- 25 Apr 2023
- Cold Call Podcast
Using Design Thinking to Invent a Low-Cost Prosthesis for Land Mine Victims
- 2022
- Working Paper
Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions
By: George P. Ball, Jeffrey T. Macher and Ariel Dora Stern
Medical device firms operate at the frontiers of innovation. When functioning properly, innovative medical devices can prolong and improve lives; when malfunctioning, the same devices may harm patients and lead to product recalls. Product recalls create significant... View Details
Keywords: New Product Development; Recalls; Product Failures; Medical Devices; FDA; Health Care; Product Development; Product; Failure; Competition; Opportunities; Medical Devices and Supplies Industry
Ball, George P., Jeffrey T. Macher, and Ariel Dora Stern. "Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions." Harvard Business School Working Paper, No. 19-028, September 2018. (Revised March 2022.)
- 09 Jun 2022
- HBS Case
From Truck Driver to Manager: US Foods’ Novel Approach to Staff Shortages
In 2021, US Foods faced a problem that has become all too familiar: As thousands of Americans re-evaluated their work lives in the middle of the pandemic, the company—one of the largest food service distributors in the United... View Details
Keywords: by Pamela Reynolds
- August 2012 (Revised August 2014)
- Case
Cancer Treatment Centers of America® (A)
By: Regina E. Herzlinger and Natalie Kindred
Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who... View Details
Keywords: Cancer; Cancer Treatment; Health Care; Healthcare; Accountability; Outcomes; Outcomes Measurement; Outcomes Reporting; Hub And Spoke Cancer Care; Hub And Spoke; Hub-and-spoke; Focused Factory; Mission and Purpose; Private Ownership; For-Profit Firms; Health Disorders; Medical Specialties; Policy; Business Model; Expansion; Decision Choices and Conditions; Advertising; Health Care and Treatment; Innovation and Invention; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
- November–December 2015
- Article
Active Postmarketing Drug Surveillance for Multiple Adverse Events
By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical... View Details
Keywords: Drug Surveillance; Health Care; Stochastic Models; Queueing; Diffusion Approximation; Brownian Motion; Health Care and Treatment; Analytics and Data Science; Analysis
Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios. "Active Postmarketing Drug Surveillance for Multiple Adverse Events." Operations Research 63, no. 6 (November–December 2015): 1528–1546. (Finalist, 2012 INFORMS Health Applications Society Pierskalla Award.)